Acalabrutinib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of acalabrutinib that may be used in the treatment of mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), gastric and nongastric MALT lymphoma, nodal marginal zone lymphoma (NMZL), splenic marginal zone lymphoma (SMZL), and Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.

**Synonyms:** - Acalabrutinib monotherapy - Calquence Regimen